N 2 (183) 2023. P. 42–46

THE INFLUENCE OF HIGH-FREQUENCY CHEST WALL OSCILLATION ON THE DYNAMICS OF CLINICAL SYMPTOMS OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN

Odesa National Medical University, Odesa, Ukraine

DOI 10.32782/2226-2008-2023-2-7

Introduction. Pneumonia remains an important medical and social problem in pediatrics and requires new modern approaches to its managment. High-frequency chest wall oscillation (HFCWO) is one of the innovative non-drug methods of restoring the drainage of the bronchial tree, which can be included in the daily therapeutic complex of pneumonia in children.

Objective. To study the influence of high-frequency chest wall oscillation on the dynamics of clinical symptoms of community-acquired pneumonia (CAP) in children.

Materials and methods. The research included 121 children aged 6 to 17 years (11.73 ± 0.53 years) with acute and uncomplicated course of moderate CAP. Among the surveyed children there were 65 (61.27±8.2%) boys and 56 (52.74±7.4%) girls, who were divided into two groups. The first group (FG) consisted of 61 children (35 boys and 26 girls), who were prescribed basic therapy (BT) and procedures of HFCWO using the device “The Vest”. The second group (SG) included 60 children (27 boys and 33 girls) who received only BT.

Results. The positive dynamics of clinical symptoms on the background of the complex treatment of acute and uncomplicated CAP with the use of HFCWO procedures was observed in children of FG due to the fact that some symptoms disappeared probably earlier. First of all, it concerned the intensity and productivity of cough, auscultatory changes in the lungs. In most children of FG was normalized by the end of the course of complex treatment, only in isolated cases there was a slight cough and sputum in a small amount. Whereas in SG children there was a productive cough and a discharge of more sputum, which required a prolongation of basic treatment.

Conclusion. The results of the study allow to recommend as an adjunct to the basic therapy of pneumonia the procedure of high-frequency chest wall oscillation to restore the functioning of the respiratory tract in children.

Key words: high-frequency chest wall oscillation, pneumonia, children.

REFERENCES

  1. Volosovets OP, Bolbot YuK, Abaturov OYe, Kryvopustov SP, Stoieva TV. Dynamics of changes in the incidence of pneumonia in children of Ukraine over the past 20 years. Medychni perspektyvy 2020; 25(4): 174–181.
  2. United Nations Children’s Fund. Every child’s right to survive: a 2020 agenda to end pneumonia deaths. 2020. Available from: https://www.unicef.org/reports/every-childs-right-survive-pneumonia-2020.
  3. Waseem M. Pediatric Pneumonia. Medscape. 2020. Available from: https://emedicine.medscape.com/article/967822-overview#a2.
  4. Arуaуev ML, Kotova NV. Pediatriia u dvokh tomakh. Zakhvoriuvannia ditei rannoho viku. Pulmonolohiia. Alerholohiia. Kardiolohiia. Hastroenterolohiia. Nefrolohiia. VIL-infektsiia. Pervynna medyko-sanitarna dopomoha [Pediatrics in two volumes. Diseases of young children. Pulmonology. Allergology. Cardiology. Gastroenterology. Nephrology. HIV infection. Primary health care]. Odesa. 2014. V. 2. P. 312.
  5. Chykyna SIu, Belevskyi AS. Mucociliary clearance in normal and pathological conditions. Atmosfera. Pulmonolohyia y allerholohyia. 2012; 1: 2–5.
  6. Munkholm M, Mortensen J. Mucociliary clearance: pathophysiological aspects. Clin Physiol Funct Imaging. 2014. № 34. Р. 171–177. doi: 10.1111/cpf.12085.
  7. Lester MK, Flume PA. Airway-clearance therapy guidelines and implementation. Respir. Care. 2009. № 54 (6). Р. 733–753. doi: 10.4187/002013209790983205.
  8. Rubin BK. Secretion properties, clearance, and therapy in airway disease. Transl Respir Med. 2014. № 2(6). doi: 10.1186/2213-0802-2-6.
  9. Hess DR. Airway Clearance and Lung Expansion Therapy, in Respiratory Care Principles and Practice. Jones and Bartlett Learning: Burlington, MA. 2016. Р. 352–379.
  10. Meshcheriakova NN, Cherniak AV. Influence of high frequency chest wall oscillation methods on the functional state of the lungs in patients with pulmonary pathology. Pulmonolohyia 2011; 5: 57–60.
  11. Gwag HB, Joh HS, Kim JS, Park Kyoung-Min, On YK, Park SJ. Safety of mechanical lung vibrator and high frequency chest wall oscillation in patients with cardiac implantable electronic device. Сlin Cardiol. 2021. Р. 1–6. doi:10.1002/clc.23571.
  12. Osman LP, Roughton M, Hodson ME, Pryor JA. Short term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis. Thorax. 2010. № 65(3). Р. 196–200. doi: 10.1136/thx.2008.111492.
  13. Symonova OІ. Airway сlearance by high frequency chest wall oscillation in the treatment of children with cystic fibrosis. Voprosy sovremennoy pediatrii. 2014; 13 (4): 110–117.
  14. Fainardi V, Longo F, Faverzani S, Tripodi MC, Chetta A, Pisi G. Short-term effects of high-frequency chest compression and positive expiratory pressure in patients with cystic fibrosis. J Clin Med Rese. 2011. № 3(6). Р. 279–284. doi: 10.4021/jocmr697w.
  15. Nakaz Ministerstva okhorony zdorovia Ukrainy № 18 vid 31 hrudnia 2005 roku «Protokol likuvannia ditei z pnevmoniieiu ». Available from: http://old.moz.gov.ua/ua/portal/dn_20050113_18.html.
  16. Arуaуev ML, Usenko DV. Evaluation and selection of high-frequency chest wall oscillation modes in children with community-acquired pneumonia based on pulse oximetry. Zaporizkyi medychnyi zhurnal. 2020; 3 (120): 378–383.
  17. Patent on the useful model 114857 Ukraine, MPC (2017.01), А 61 В 10/00, А 61В 5/0205, А 61В 5/08. The method of determining the effectiveness of treatment of acute respiratory diseases in children. M.L. Arуaуev, D.V. Usenko. № u201609413; declarant. 12.09.2016; opoub. 27.03.2017, Byol. № 6. 4 c.